Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brian Yang

Managing Editor

Beijing, China

Brian is in charge of overall China coverage within the APAC pharma news team. A veteran journalist, he has written extensively on R&D, regulatory, market access and business issues. Brian has led a team of writers providing industry-leading coverage in the second-largest health care market.

Latest From Brian Yang

China Walks Back Some Relaxations Amid New COVID Outbreaks

With growing cases and deaths reported just as the country was preparing to ease some of its most restrictive COVID-19 measures, China takes new control steps amid low booster vaccine uptake and moves to halt the online sale of a repurposed domestic antiviral.

Coronavirus COVID-19 Policy

Biotech CEO Interview: Harbour BioMed's Wang On Moderna Deal, New Subsidiary

After inking major deals with AbbVie and AstraZeneca, China-US company Harbour BioMed recently shifted strategy, divesting its site in Suzhou to WuXi in a bid to be “more focused, efficient and nimble” and emerge stronger post-pandemic, says founder, chairman and CEO Jingsong Wang in an exclusive interview.

China Strategy

Biden-Xi Bali Meet Reopens US-China Cooperation, Looks Positive For Health Players

A meeting between the heads of the world's two largest economies potentially opens the door for health cooperation, a rare positive sign amid worsening economic decoupling, accelerating diversification away from China and the need for multinationals to modify localization strategy.

Politics Strategy

China Eyes New COVID Vaccines As It Inches Towards Reopening

New planned changes around vaccine approvals and other COVID-19 measures signal China is preparing for a gradual reopening amid its strict policies, but the process could take months.

Coronavirus COVID-19 China

Show Me CIIE: Can Foreign Pharma Continue Growth Trajectory In Closing China?

The largest show for multinational pharma firms in China shows new approaches to localization may be needed as the country navigates choppy waters.

China Companies

Scholz Visit Paves Way For Limited China BioNTech Vaccine Use

Recent visits by foreign dignitaries and progress with local mRNA vaccines and antivirals appear to be helping some slight relaxations in China's strict COVID policies, but some experts predict it may still take months for further steps.

China Policy
See All
UsernamePublicRestriction

Register